Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
46 /100
MEDIUM RISK
Score updated Aug 28, 2026

PRQR — ProQR Therapeutics N.V. Dilution Risk Tracker

Track PRQR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRQR — Get alerts when the score changes →

As of August 28, 2026, ProQR Therapeutics N.V. (PRQR) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. ProQR Therapeutics N.V. has a market capitalization of $166.47M, 105.36M shares outstanding, 70 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.64 approaching $1 threshold
🔔 Track PRQR — Get forecast alerts →

Market Data

Market Cap$166.47M
Shares Outstanding105.36M
Float64.35M
Cash$94.54M
Debt$18.34M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 7.0% shares (2026Q1 vs prior)
70 institutional holders · 39.98M shares
#1 ADAGE CAPITAL PARTNERS GP, L.L.C. 6.25M shares
#2 MORGAN STANLEY 5.57M shares
#3 Privium Fund Management B.V. 5.47M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.22M
Days to Cover2.8
% of Float3.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track PRQR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PRQR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT AATC AEHR AEMRF AGGID AGM AHRT AIJTY ALDX ALOT

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PRQR
PRQR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.